Cargando…

Longitudinal micro-CT as an outcome measure of interstitial lung disease in TNF-transgenic mice

INTRODUCTION: Rheumatoid arthritis associated interstitial lung disease (RA-ILD) is a debilitating condition with poor survival prognosis. High resolution computed tomography (CT) is a common clinical tool to diagnose RA-ILD, and is increasingly being adopted in pre-clinical studies. However, murine...

Descripción completa

Detalles Bibliográficos
Autores principales: Bell, Richard D., Rudmann, Christopher, Wood, Ronald W., Schwarz, Edward M., Rahimi, Homaira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761871/
https://www.ncbi.nlm.nih.gov/pubmed/29320550
http://dx.doi.org/10.1371/journal.pone.0190678
_version_ 1783291605606727680
author Bell, Richard D.
Rudmann, Christopher
Wood, Ronald W.
Schwarz, Edward M.
Rahimi, Homaira
author_facet Bell, Richard D.
Rudmann, Christopher
Wood, Ronald W.
Schwarz, Edward M.
Rahimi, Homaira
author_sort Bell, Richard D.
collection PubMed
description INTRODUCTION: Rheumatoid arthritis associated interstitial lung disease (RA-ILD) is a debilitating condition with poor survival prognosis. High resolution computed tomography (CT) is a common clinical tool to diagnose RA-ILD, and is increasingly being adopted in pre-clinical studies. However, murine models recapitulating RA-ILD are lacking, and CT outcomes for inflammatory lung disease have yet to be formally validated. To address this, we validate μCT outcomes for ILD in the tumor necrosis factor transgenic (TNF-Tg) mouse model of RA. METHODS: Cross sectional μCT was performed on cohorts of male TNF-Tg mice and their WT littermates at 3, 4, 5.5 and 12 months of age (n = 4–6). Lung μCT outcomes measures were determined by segmentation of the μCT datasets to generate Aerated and Tissue volumes. After each scan, lungs were obtained for histopathology and 3 sections stained with hematoxylin and eosin. Automated histomorphometry was performed to quantify the tissue area (nuclei, cytoplasm, and extracellular matrix) and aerated area (white space) within the tissue sections. Spearman’s correlation coefficients were used to evaluate the extent of association between μCT imaging and histopathology endpoints. RESULTS: TNF-Tg mice had significantly greater tissue volume, total lung volume and mean intensity at all timepoints compared to age matched WT littermates. Histomorphometry also demonstrated a significant increase in tissue area at 3, 4, and 5.5 months of age in TNF-Tg mice. Lung tissue volume was correlated with lung tissue area (ρ = 0.81, p<0.0001), and normalize lung aerated volume was correlated with normalized lung air area (ρ = 0.73, p<0.0001). CONCLUSIONS: We have validated in vivo μCT as a quantitative biomarker of ILD in mice. Further, development of longitudinal measures is critical for dissecting pathologic progression of ILD, and μCT is a useful non-invasive method to study lung inflammation in the TNF-Tg mouse model.
format Online
Article
Text
id pubmed-5761871
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-57618712018-01-23 Longitudinal micro-CT as an outcome measure of interstitial lung disease in TNF-transgenic mice Bell, Richard D. Rudmann, Christopher Wood, Ronald W. Schwarz, Edward M. Rahimi, Homaira PLoS One Research Article INTRODUCTION: Rheumatoid arthritis associated interstitial lung disease (RA-ILD) is a debilitating condition with poor survival prognosis. High resolution computed tomography (CT) is a common clinical tool to diagnose RA-ILD, and is increasingly being adopted in pre-clinical studies. However, murine models recapitulating RA-ILD are lacking, and CT outcomes for inflammatory lung disease have yet to be formally validated. To address this, we validate μCT outcomes for ILD in the tumor necrosis factor transgenic (TNF-Tg) mouse model of RA. METHODS: Cross sectional μCT was performed on cohorts of male TNF-Tg mice and their WT littermates at 3, 4, 5.5 and 12 months of age (n = 4–6). Lung μCT outcomes measures were determined by segmentation of the μCT datasets to generate Aerated and Tissue volumes. After each scan, lungs were obtained for histopathology and 3 sections stained with hematoxylin and eosin. Automated histomorphometry was performed to quantify the tissue area (nuclei, cytoplasm, and extracellular matrix) and aerated area (white space) within the tissue sections. Spearman’s correlation coefficients were used to evaluate the extent of association between μCT imaging and histopathology endpoints. RESULTS: TNF-Tg mice had significantly greater tissue volume, total lung volume and mean intensity at all timepoints compared to age matched WT littermates. Histomorphometry also demonstrated a significant increase in tissue area at 3, 4, and 5.5 months of age in TNF-Tg mice. Lung tissue volume was correlated with lung tissue area (ρ = 0.81, p<0.0001), and normalize lung aerated volume was correlated with normalized lung air area (ρ = 0.73, p<0.0001). CONCLUSIONS: We have validated in vivo μCT as a quantitative biomarker of ILD in mice. Further, development of longitudinal measures is critical for dissecting pathologic progression of ILD, and μCT is a useful non-invasive method to study lung inflammation in the TNF-Tg mouse model. Public Library of Science 2018-01-10 /pmc/articles/PMC5761871/ /pubmed/29320550 http://dx.doi.org/10.1371/journal.pone.0190678 Text en © 2018 Bell et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Bell, Richard D.
Rudmann, Christopher
Wood, Ronald W.
Schwarz, Edward M.
Rahimi, Homaira
Longitudinal micro-CT as an outcome measure of interstitial lung disease in TNF-transgenic mice
title Longitudinal micro-CT as an outcome measure of interstitial lung disease in TNF-transgenic mice
title_full Longitudinal micro-CT as an outcome measure of interstitial lung disease in TNF-transgenic mice
title_fullStr Longitudinal micro-CT as an outcome measure of interstitial lung disease in TNF-transgenic mice
title_full_unstemmed Longitudinal micro-CT as an outcome measure of interstitial lung disease in TNF-transgenic mice
title_short Longitudinal micro-CT as an outcome measure of interstitial lung disease in TNF-transgenic mice
title_sort longitudinal micro-ct as an outcome measure of interstitial lung disease in tnf-transgenic mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761871/
https://www.ncbi.nlm.nih.gov/pubmed/29320550
http://dx.doi.org/10.1371/journal.pone.0190678
work_keys_str_mv AT bellrichardd longitudinalmicroctasanoutcomemeasureofinterstitiallungdiseaseintnftransgenicmice
AT rudmannchristopher longitudinalmicroctasanoutcomemeasureofinterstitiallungdiseaseintnftransgenicmice
AT woodronaldw longitudinalmicroctasanoutcomemeasureofinterstitiallungdiseaseintnftransgenicmice
AT schwarzedwardm longitudinalmicroctasanoutcomemeasureofinterstitiallungdiseaseintnftransgenicmice
AT rahimihomaira longitudinalmicroctasanoutcomemeasureofinterstitiallungdiseaseintnftransgenicmice